· 21 min read
TB-500 Dosage Chart, Molecule Identity, and 2026 FDA Status
TB-500 vial math for 2, 5 and 10 mg, why TB-500 is not thymosin beta-4, what the human trials actually used, and the July 2026 FDA advisory review.
Healing and Recovery
BPC-157, TB-500 and the stacks used for tendon, ligament, gut and soft tissue repair.
· 6 min read
Peptides for Injury Recovery: Evidence & Protocols
Peptides for injury recovery: what the research shows on BPC-157, TB-500, and GHK-Cu for tissue repair, plus stacking considerations and precautions.
· 19 min read
What Is the GLOW Blend Peptide? Benefits, Dosing, and Risks Explained
Learn what the GLOW Peptide Blend is, how GHK-Cu, TB-500, and BPC-157 work together for systemic recovery and anti-aging, and what the research says about benefits, dosing, and risks.
· 14 min read
Cartalax Peptide (Khavinson Cartilage Bioregulator): Benefits, Dosage, Mechanism, and Safety
What Cartalax peptide is, how the Khavinson cartilage bioregulator is proposed to work, what the research shows, dosing formats, safety, and how it compares.
· 17 min read
GHK-Cu Peptide: Benefits, Mechanisms, and Anti-Aging Research
Little-known copper peptide shot boosts collagen, repairs skin, and helps biohackers slow visible aging, with promising support from emerging research.
· 17 min read
Wolverine Protocol: BPC-157 + TB-500 Stack for Accelerated Tissue Repair
BPC-157 and TB-500 are the two most researched healing peptides available. This protocol covers exact stack ratios, dosing frequency, cycle length, and what the research actually shows.
· 15 min read
KPV Peptide: Benefits, Dosage, Gut Health, and Anti-Inflammatory Guide
Discover what KPV peptide is, how it works, its anti-inflammatory benefits, research-backed dosage ranges, safety profile, and current scientific evidence.
· 23 min read
Is BPC-157 Safe? 2026 Evidence Review (FDA, WADA, Human Data)
BPC-157 isn't FDA approved and was banned by WADA in 2022. What human pilot studies, 2025 reviews, and angiogenesis cancer concerns mean for safety decisions.